CATALOGO DEI PRODOTTI DELLA RICERCA

ADAMI, Silvano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.031
EU - Europa 17.915
AS - Asia 5.120
SA - Sud America 50
OC - Oceania 23
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 9
Totale 41.166
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.974
GB - Regno Unito 8.662
CN - Cina 3.559
DE - Germania 1.445
FR - Francia 1.430
SE - Svezia 1.399
FI - Finlandia 1.182
RU - Federazione Russa 1.109
IE - Irlanda 1.100
SG - Singapore 982
IT - Italia 853
UA - Ucraina 509
TR - Turchia 203
VN - Vietnam 139
JP - Giappone 87
BE - Belgio 64
CA - Canada 43
NL - Olanda 36
IR - Iran 31
CL - Cile 25
IL - Israele 24
CZ - Repubblica Ceca 22
IN - India 21
KR - Corea 21
AU - Australia 18
BR - Brasile 17
ES - Italia 15
HK - Hong Kong 14
PL - Polonia 13
MX - Messico 10
RO - Romania 10
BG - Bulgaria 9
CH - Svizzera 7
A2 - ???statistics.table.value.countryCode.A2??? 6
AT - Austria 5
EG - Egitto 5
HU - Ungheria 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
QA - Qatar 5
TW - Taiwan 5
CM - Camerun 4
HR - Croazia 4
LV - Lettonia 4
MD - Moldavia 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
ZA - Sudafrica 4
AR - Argentina 3
EU - Europa 3
PK - Pakistan 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
DK - Danimarca 2
IM - Isola di Man 2
IQ - Iraq 2
JM - Giamaica 2
KG - Kirghizistan 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
MA - Marocco 2
PE - Perù 2
RS - Serbia 2
SC - Seychelles 2
AM - Armenia 1
AZ - Azerbaigian 1
BY - Bielorussia 1
BZ - Belize 1
CO - Colombia 1
CY - Cipro 1
EC - Ecuador 1
GR - Grecia 1
ID - Indonesia 1
IS - Islanda 1
JO - Giordania 1
LT - Lituania 1
MC - Monaco 1
ME - Montenegro 1
MK - Macedonia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MS - Montserrat 1
NG - Nigeria 1
OM - Oman 1
PH - Filippine 1
TH - Thailandia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 41.166
Salva come PNG Salva come JPEG
Città #
Southend 8.019
Jacksonville 4.356
Chandler 2.545
Woodbridge 2.100
Ann Arbor 1.668
Houston 1.174
Dublin 1.095
Ashburn 817
Singapore 639
Wilmington 551
Lawrence 540
Princeton 540
Nanjing 423
Beijing 390
Jinan 390
Shenyang 337
New York 244
Sindelfingen 233
Boardman 228
Hebei 222
Helsinki 201
Tianjin 163
Milan 159
Changsha 158
Verona 158
Dong Ket 134
Nanchang 133
Haikou 122
Jiaxing 113
Zhengzhou 112
Ningbo 111
Hangzhou 99
Taizhou 96
Guangzhou 80
Falls Church 73
Tokyo 72
Taiyuan 71
Norwalk 68
Brussels 63
Philadelphia 60
Detroit 56
Fairfield 56
Lanzhou 56
Fuzhou 47
Lancaster 47
Los Angeles 43
Seattle 41
Dearborn 40
Bologna 38
Washington 38
Düsseldorf 37
Redmond 35
Orani 33
Auburn Hills 29
Redwood City 29
San Francisco 29
Chicago 23
Dallas 23
Paris 21
Toronto 21
Columbus 20
Tappahannock 19
Greifswald 18
Nürnberg 18
Cambridge 16
San Diego 16
West Jordan 16
Edinburgh 15
Rome 15
Sanayi 15
Amsterdam 14
Kent 14
Phoenix 14
Clearwater 13
Leawood 13
London 13
Frankfurt am Main 12
Dongguan 11
Novokuznetsk 11
Olomouc 11
Venice 11
Warsaw 11
Mexico City 10
Seoul 10
Torino 10
Walsall 10
Brno 9
Mehlingen 9
Moscow 9
Ypsilanti 9
Hanover 8
Hong Kong 8
Kemerovo 8
Sacramento 8
San Jose 8
Zanjan 8
Denver 7
Melbourne 7
Montréal 7
Turin 7
Totale 29.967
Salva come PNG Salva come JPEG
Nome #
1,25 (OH) 2D3 stimulates and bisphosphonates inhibit fibronectin release by human microphages. 252
1,25-dihydroxy vitamin D in primary hyperparathyroidism 248
Teriparatide and denosumab combination therapy and skeletal metabolism 243
La correzione dell’ipovitaminosi D nel lungo termine: confronto tra diverse modalità di somministrazione di vitamina D nella pratica clinica. 169
Artrite Reumatoide e Metabolismo Minerale 164
Il trattamento del morbo di Paget con calcitonina umana: influenza della secrezione paratoidea e dei titoli di anticorpi anti-calcitonina (umana e porcina) 148
The effects of menopause and estrogen replacement therapy on the renal handling of calcium 140
12 month-retrospective analysis of two different rituximab retreatment regimens in rheumatoid arthritis:retreatment at clinical relapse Vs 6 (th) month fixed retreatment 137
Association of CTR and COLIA1 alleles with BMD values in peri and postmenopausal women 135
Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells. 134
Trattamento dell'osteoporosi cortisonica con Nandrolone Decanoato 130
Incidenza di ipovitaminosi D nel Nord Italia 128
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 128
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 127
Sustained vertebral fracture risk reduction after withdrowal of teriparatide in postmenopausal women with osteoporosis 124
Effects of therapeutic doses of salbutamol alone and combined with beclomethasone dipropionate on airway responsiveness and cyclic AMP plasma levels in asthmatic patients 123
Serum thyroid hormone concentrations and weight loss relationships in eight obese women during semistarvation 123
Discriminant analysis in the differential diagnosis of hypercalcaemia 122
[The long term correction of vitamin D deficiency: comparison between different treatments with vitamin D in clinical practice.]. 122
Fasting serum gastrin in primary hyperparathyroidism and in chronic hypercalcemia 121
25-OH-D metabolism in primary hyperparathyroidism 119
12 month-retrospective analysis of two different Rituximab pretreatment regimens in Rheumatoid Arthritis: retreatment at clinical relapse versus 6th month fixed pretreatment. 119
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 118
[Studies on the therapeutic efficacy of a new diuretic combination in patients with edema of hepatic and cardiac etiology] 115
Circdian rhytm in serum PTH concentration in normal subjects and in primary hyperparathyroidoism: correlation with ionized serum calcium 115
Primary hyperparathyroidism: diagnostic value of a model of multivariate statistical analysis 114
[Acid-base balance in primary hyperparathyroidism] 114
L'attività xantino-ossidasica epatocitaria nelle siderocromatosi primitive e secondarie 114
PAEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDER ASSOCIATED WITH GROUP A STREPTOCOCCAL INFECTION (PANDAS): CARDIAC AND ARTICULAR INVOLVEMENT 114
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 114
Clinical utility of a wheat-germ precipitation assay for determination of bone alkaline phosphatase concentrations in patients with different metabolic bone diseases 113
[Serum calcium evaluation and incidence of primary hyperparathyroidism in hospitalized patients (author's transl)] 113
Rapporti tra sistema immune e metabolismo osseo 113
The ultrastructure of bone cells and bone matrix in human primary hyperparathyroidism 112
DXA bone mineral density in males: retrospective study in real life. 111
[Rational bases for the treatment of osteoporosis] 111
[Incidence of thyroid diseases in primary hyperparathyroidism] 110
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 110
Aberration in vitamin D metabolism during mianserin treatment [letter] 109
Effects of nandrolone decanoate (Decadurabolin) on serum Lp(a), lipids and lipoproteins in women with postmenopausal osteoporosis 109
Il dosaggio del calcio ionizzato nelle alterazioni del metabolismo fosfo-calcico 109
Prevalence and incidence of rheumatoid arthritis in Italy. 109
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 109
[Therapeutic strategies in osteoporosis: whom and when to treat] 108
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 107
Valore del dosaggio radioimmunologico del paratormone plasmatico nella diagnosi di iperparatiroidismo primitivo 107
Age-related bone loss in postmenopausal women 107
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 106
Somatostatin inhibition of insulin secretion in insulin-producing tumors 106
A NEW CONCEPT FOR BISPHOSPHONATE THERAPY: A RATIONALE FOR THE DEVELOPMENT OF MONTHLY ORAL DOSING OF IBANDRONATE 106
Contributo allo studio del meccanismo d'azione ipouricemizzante del benziodarone 103
25-hydroxyvitamin D levels in healthy premenopausal wome: association with bone turnover markers and bone mineral density 103
The early psoriatic arthritis screening questionnaire: a simple and fast method for the identification of arthritis in patients with psoriasis 103
Digital Amputation in Systemic Sclerosis: Prevalence and Clinical Associations. A Retrospective Longitudinal Study. 103
Simultaneous measurement of 1.25-dihydroxy-vitamin D, 24.25-dihydroxy-vitamin D and 25-hydroxy-vitamin D from a single two milliliters serum specimen. Preliminary clinical application 102
The renal handling of calcium: influence of parathyroid hormone secretion 102
Growth Hormone in Combination with Bisphosphonate Treatment in Osteogenesis Imperfecta. 102
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 102
Valutazione ecografia con power doppler delle entesi in età pediatrica 102
Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone 102
Power Doppler ultrasonographic findings in healthy pediatric entheses 102
Adverse effects of bisphosphonates. A comparative review 101
Response of Paget's disease to human calcitonin in patients resistant to porcine calcitonin 101
Effects of oral alendronate and intranasal samon calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosis 101
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 101
Osteopetrosi 101
Osteoporosis treatment: why ibandronic acid? 101
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 101
Suppressive effect of chronic glucocorticoid treatment on circulating calcitonin in man 100
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 100
Bone mineral metabolism in girls with precocious puberty during gonadotrophin-releasing hormone agonist treatment 99
Effect of hyperandrogenism and menstrual cycle abnormalities on bone mass and bone turnover in young women 99
Long tem effects of the 25-hydroxychalciferol (25 OHD3) con PTH secretion in primary hyperparathyroid patients 99
Analisi di linkage di geni candidati per densità minerale 99
Hypo-hyperparathyroidism with normal 1,25 dihydroxycholecalciferol. 98
Vitamin D levels in patients with psoriasis with or without arthritis 98
Prevalence of osteoporosis in patients affected by mastocytosis 98
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 98
Spie metaboliche precoci delle alterazioni ossee nell'iperparatiroidismo primitivo 97
Incidenza di ipovitaminosi D nel Nord Italia 97
Intermittent etidronate partially prevents bone loss in hirsute hyperandrogenic women treated with GnRH Agonist. 97
The time course of a hypercalcaemic crisis in acute primary hyperparathyroidism [letter] 96
Anabolic steroids in corticosteroid-induced osteoporosis 96
[Comparative studies of the behavior of blood calcium and urinary hydroxyproline after infusion of calcitonin and glucagon in patients with Paget's disease] 96
Association between bone mineral density and serum lipid in men 96
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 96
Competitive protein binding assay for 25-hydroxyvitamin D. 96
Primi rilievi sull'utilità del dosaggio radioimmunologico del paratormone nella diagnosi di iperparatiroidismo primitivo 95
Prathyroid hormone increase after secretin infusion 95
Effetto della somministrazione cronica di 25-OH-colecalciferolo sui livelli plasmatici di PTH, 1.25(OH)2d e 24,25 (OH)2D, in pazienti affetti da iperparatiroidismo primitivo. 95
The role of changes in calcitonin (CT), parathyroid hormone (PTH) and acid-base balance on the reduction of bone turnover (BT) after an oral calcium load (OCL) 95
Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness 95
Rituximab increases peripheral natural killer cells in patients with rheumatoid arthritis 95
Vitamin D metabolites in severe hypercalcemic parathyroid crises 94
Intravenous intermittent neridronate in the treatment of postmenopausal osteoporosis. 94
Failure of somatostatin to diagnose organic hyperinsulinism 94
Safety issues and adverse reactions with osteoporosis management 94
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 94
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 94
Effects of 25-OH-D3 and 24-25 8OH) 2d3 treatment in primary hyperparathyroid patients, 93
Totale 11.274
Salva come PNG Salva come JPEG
Categoria #
all - tutte 123.194
article - articoli 115.125
book - libri 0
conference - conferenze 4.016
curatela - curatele 0
other - altro 728
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.325
Totale 246.388
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.654 0 0 30 578 622 534 494 724 254 550 134 734
2020/20215.125 472 921 159 482 618 613 40 495 435 24 597 269
2021/20223.764 255 941 33 133 264 217 41 236 178 122 437 907
2022/20237.875 707 527 981 1.247 764 1.866 64 514 788 57 252 108
2023/20243.313 204 295 305 498 453 386 121 257 34 108 410 242
2024/20251.476 680 796 0 0 0 0 0 0 0 0 0 0
Totale 41.456